Evaluation of Persistence of Anti-meningococcal Bactericidal Antibodies Among Adolescents Who Previously Received MenACWY Conjugate Vaccine - NCT00856297-44121 (Clinical Trial 275999)
Permalink: http://www.ClinicalConnection.com/exp/ExpandedPatientViewStudy275999.aspx
|
** Please review additional "Nearby Studies" on right ----->
|
|
 |
 |
|
| City: |
|
South Euclid |
|
State:
|
|
OH |
| Zip Code: |
|
44121 |
| Conditions: |
|
Meningococcal Meningitis |
| Purpose: |
|
The primary objective is to evaluate the persistence of bactericidal antibodies in
adolescents previously enrolled in the V59P13 study who received either Novartis MenACWY
Conjugate Vaccine or commercial available MenACWY conjugate vaccine. The study will also
enroll age-matched subjects who have never received any other meningococcal vaccine (naïve
subjects) to serve as an additional control group.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Subjects enrolled in V59P13
- Healthy, who have completed the V59P13 study and are in good health;
- Naïve subjects
- Healthy children aged-matched with subjects enrolled in V59P13 trial.
Exclusion Criteria:
Subjects enrolled in V59P13:
- who received any meningococcal vaccine after V59P13 trial;
- who have had a previous confirmed or suspected disease caused by N. meningitidis;
- who have had household contact with and/or intimate exposure to an individual with
culture-proven N. meningitidis (serogroups A, C, W135, or Y);
- Subjects with any serious, acute or chronic progressive disease. Naïve subjects
- who previously received any meningococcal vaccine;
- who have had a previous confirmed or suspected disease caused by N. meningitidis;
- who have had household contact with and/or intimate exposure to an individual with
culture-proven N. meningitidis (serogroups A, C, W135, or Y);
- Subjects with any serious, acute or chronic progressive disease. |
|
|
|
| Study is available at: |
|
Dr. Senders and Associates
South Euclid, OH 44121
United States
Primary Contact:
Novartis Drug Information Services
Phone: +1 800 244 7668 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 16, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinical trials are medical research studies designed to test the safety and/or
effectiveness of new drugs, devices, or treatments in humans. These studies are
conducted worldwide for a range of conditions and illnesses. Learn more about
clinical research and participating in a study at
About Clinical Trials.
|
|
|
|
|